Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfide bond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy

References

• Bekkara-Aounallah F, Gref R, Othman M, et al. (2008). Novel PEGylated nanoassemblies made of self-assembled squalenoyl nucleoside analogues. Adv Funct Mater 18:3715–25.
   Web of Science ®Google Scholar
• Bloise E, Braca A, De Tommasi N, et al. (2009). Pro-apoptotic and cytostatic activity of naturally occurring cardenolides. Cancer Chemother Pharmacol 64:793–802.
   PubMed Web of Science ®Google Scholar
• Cao X, Fu M, Wang L, et al. (2012). Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles. Acta Biomater 8:2104–12.
   PubMed Web of Science ®Google Scholar
• Cong L, Jin S, Dan L, et al. (2016). Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy. Nano Lett 16:5401–8.
   PubMed Web of Science ®Google Scholar
• Dastidar P, Roy R, Bhagyalalitha M, et al. (2016). Salt metathesis for developing injectable supramolecular metallohydrogelators as multi-drug-self-delivery system. Chem Commun 52:13811–4.
   PubMed Web of Science ®Google Scholar
• Denicolaï E, Baezakallee N, Tchoghandjian A, et al. (2014). Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo. Oncotarget 5:10934–48.
   PubMed Web of Science ®Google Scholar
• Diederich M, Muller F, Cerella C. (2017). Cardiac glycosides: from molecular targets to immunogenic cell death. Biochem Pharmacol 125:1–11.
   PubMed Web of Science ®Google Scholar
• Gaudin A, Song E, King AR, et al. (2016). PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma. Biomaterials 105:136–44.
   PubMed Web of Science ®Google Scholar
• Gaudin A, Tagit O, Sobot D, et al. (2015). Transport mechanisms of squalenoyl adenosine nanoparticles across the blood–brain barrier. Chem Mater 27:3636–47.
   Web of Science ®Google Scholar
• Gong C, Wei X, Wang X, et al. (2010). Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization. Nanotechnology 21:215103.
   PubMed Web of Science ®Google Scholar
• Haux J. (1999). Digitoxin is a potential anticancer agent for several types of cancer. Med Hypotheses 53:543–8.
   PubMed Web of Science ®Google Scholar
• Langenhan JM, Peters NR, Guzei IA, et al. (2005). Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization. Proc Natl Acad Sci USA 102:12305–10.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang L, Lin Y, et al. (2016). A pH-sensitive prodrug micelle self-assembled from multi-doxorubicin-tailed polyethylene glycol for cancer therapy. RSC Adv 6:9160–3.
   Web of Science ®Google Scholar
• Li W, Lin X, Yang Z, et al. (2015). A bufadienolide-loaded submicron emulsion for oral administration: stability, antitumor efficacy and toxicity. Int J Pharm 479:52–62.
   PubMed Web of Science ®Google Scholar
• Li Y, Liu YB, Yu SS, et al. (2012). Cytotoxic cardenolides from the stems of Periploca forrestii. Steroids 77:375–81.
   PubMed Web of Science ®Google Scholar
• Lin Q, Yang L, Hu Q, et al. (2016). Injectable supramolecular hydrogel formed from α-cyclodextrin and PEGlated arginine-functionalized poly(l-lysine) dendron for sustained MMP-9 shRNA plasmid delivery. Acta Biomater 49:456–71.
   PubMed Web of Science ®Google Scholar
• Liu H, Li Y, Lv Z, et al. (2014). Enzyme-triggered supramolecular self-assembly of platinum prodrug with enhanced tumor-selective accumulation and reduced systemic toxicity. J Mater Chem B 2:8303–9.
   PubMed Web of Science ®Google Scholar
• Lu J, Liu C, Wang P, et al. (2015). The self-assembling camptothecin-tocopherol prodrug: an effective approach for formulating camptothecin. Biomaterials 62:176–87.
   PubMed Web of Science ®Google Scholar
• Luo C, Sun J, Sun B, et al. (2016). Facile fabrication of tumor redox-sensitive nanoassemblies of small-molecule oleate prodrug as potent chemotherapeutic nanomedicine. Small 12:6353–62.
   PubMed Web of Science ®Google Scholar
• Luo XJ, Yang HY, Niu LN, et al. (2015). Translation of a solution-based biomineralization concept into a carrier-based delivery system via the use of expanded-pore mesoporous silica. Acta Biomater 31:1995–2002.
   Web of Science ®Google Scholar
• Mijatovic T, Van Quaquebeke E, Delest B, et al. (2007). Cardiotonic steroids on the road to anti-cancer therapy. Biochim Biophys Acta 1776:32–57.
   PubMed Web of Science ®Google Scholar
• Milutinovic S, Heynen-Genel S, Chao E, et al. (2016). Cardiac glycosides activate the tumor suppressor and viral restriction factor promyelocytic leukemia protein (PML). PLoS One 11:e0152692.
   PubMed Web of Science ®Google Scholar
• Moreno YBL, Urban E, Gelbcke M, et al. (2013). Structure–activity relationship analysis of bufadienolide-induced in vitro growth inhibitory effects on mouse and human cancer cells. J Nat Prod 76:1078–84.
   PubMed Web of Science ®Google Scholar
• Newman RA, Yang P, Pawlus AD, et al. (2008). Cardiac glycosides as novel cancer therapeutic agents. Mol Interv 8:36–49.
   PubMed Web of Science ®Google Scholar
• Otsuka H, Nagasaki Y, Kataoka K. (2012). PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev 64:246–55.
   Web of Science ®Google Scholar
• Prassas I, Diamandis EP. (2008). Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov 7:926–35.
   PubMed Web of Science ®Google Scholar
• Qin L, Wang W, Zhou Y, et al. (2016a). Preparation, characterization and in vitro antioxidant effect of glutathione (GSH) intercalation into layered double hydroxide nanoparticles for sports nutrition supplements. Nanomed Nanotechnol 12:544.
   Web of Science ®Google Scholar
• Qin SY, Zhang AQ, Cheng SX, et al. (2016b). Drug self-delivery systems for cancer therapy. Biomaterials 112:234–47.
   PubMed Web of Science ®Google Scholar
• Ralayranaivo B, Desmaële D, Bianchini EP, et al. (2014). Novel self assembling nanoparticles for the oral administration of fondaparinux: synthesis, characterization and in vivo evaluation. J Control Release 194:323–31.
   PubMed Web of Science ®Google Scholar
• Ramasamy T, Haidar ZS, Tran TH, et al. (2014). Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs. Acta Biomater 10:5116–27.
   PubMed Web of Science ®Google Scholar
• Sha J, Wan J, Meng L, et al. (2015). Biodegradation and toxicity of protease/redox/pH stimuli-responsive PEGlated PMAA nanohydrogels for targeting drug delivery. ACS Appl Mater Interfaces 7:19843–52.
   PubMed Web of Science ®Google Scholar
• Soenen SJ, Manshian B, Doak SH, et al. (2013). Fluorescent non-porous silica nanoparticles for long-term cell monitoring: cytotoxicity and particle functionality. Acta Biomater 9:9183–93.
   PubMed Web of Science ®Google Scholar
• Tian X, Yin H, Zhang S, et al. (2014). Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma. Eur J Pharm Biopharm 87:445–53.
   PubMed Web of Science ®Google Scholar
• Wang H, Xie H, Wang J, et al. (2015). Self-assembling prodrugs by precise programming of molecular structures that contribute distinct stability, pharmacokinetics, and antitumor efficacy. Adv Funct Mater 25:4956–65.
   Web of Science ®Google Scholar
• Wang Y, Liu D, Zheng Q, et al. (2014). Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines. Nano Lett 14:5577–83.
   PubMed Web of Science ®Google Scholar
• Xu Z, Liu S, Kang Y, et al. (2015). Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy. Nanoscale 7:5859–68.
   PubMed Web of Science ®Google Scholar
• Xue P, Liu D, Wang J, et al. (2016). Redox-sensitive citronellol-cabazitaxel conjugate: maintained in vitro cytotoxicity and self-assembled as multifunctional nanomedicine. Bioconjug Chem 27:1360–72.
   PubMed Web of Science ®Google Scholar
• Yan K, Wang X, Jia Y, et al. (2016). Quantitative determination of periplocymarin in rat plasma and tissue by LC–MS/MS: application to pharmacokinetic and tissue distribution study. Biomed Chromatogr 30:1195–201.
   PubMed Web of Science ®Google Scholar
• Yi C, Fu M, Cao X, et al. (2013a). Enhanced oral bioavailability and tissue distribution of a new potential anticancer agent, Flammulina velutipes sterols, through liposomal encapsulation. J Agric Food Chem 61:5961–71.
   PubMed Web of Science ®Google Scholar
• Yi C, Sun C, Tong S, et al. (2013b). Cytotoxic effect of novel Flammulina velutipes sterols and its oral bioavailability via mixed micellar nanoformulation. Int J Pharm 448:44–50.
   PubMed Web of Science ®Google Scholar
• Yi C, Zhong H, Tong S, et al. (2012). Enhanced oral bioavailability of a sterol-loaded microemulsion formulation of Flammulina velutipes, a potential antitumor drug. Int J Nanomed 7:5067–78.
   PubMed Web of Science ®Google Scholar
• Zhang HY, Xu WQ, Wang YW, et al. (2016a). Tumor targeted delivery of octreotide-periplogenin conjugate: synthesis, in vitro and in vivo evaluation. Int J Pharm 502:199–200.
   Web of Science ®Google Scholar
• Zhang HY, Xu WQ, Zheng YY, et al. (2016b). Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation. Oncotarget 7:86326–38.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Peng W, Zhang J, et al. (2014). Enhanced oral bioavailability of capsaicin in mixed polymeric micelles: preparation, in vitro and in vivo evaluation. J Funct Foods 8:358–66.
   Web of Science ®Google Scholar